Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leonurus injection after induced abortion
ChiCTR-IPR-15006621Phase 4Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Jun 2015
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Motherwort in postabortion hemorrhage (PAH) (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: Amount of bleeding. Started Jun 2015; status: recruiting.
02
Drugs
Motherwort
03
Conditions
postabortion hemorrhage (PAH)
Beyond the preview
Go deeper on ChiCTR-IPR-15006621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006621.